MOUNTAIN VIEW, Calif., Oct. 21IRIDEX Corporation (Nasdaq: IRIX) today announced the introduction of the IQ 532(TM) dual-port ophthalmic green laser photocoagulator which will be featured at the 2009 American Academy of Ophthalmology meeting in San Francisco.
"The IQ 532 represents the latest addition to the IRIDEX family of IQ laser systems," commented Theodore A. Boutacoff, President & CEO. "With the IQ 532, physicians can perform a wide range of clinical applications using the latest solid-state laser technology with two notable new features. One is dual-port laser output. Physicians may connect a delivery device to each laser port and then switch between devices without changing connections. Another is the user interface featuring: an easy to use touchscreen with options for storing system presets such as physician treatment settings; and voice confirmation. Both features add convenience and save time by accelerating system setup and operation."
The IQ 532 is the eighth ophthalmic laser in IRIDEX' current product line of laser photocoagulators each tailored to satisfy specific needs of the ophthalmic surgeon. The IQ 532 adds to the portfolio of photocoagulator systems known for their high quality and reliability, as well as efficient designs for quick and effective depot servicing.
IRIDEX Corporation was founded in 1989 and is a worldwide leader in developing, manufacturing, and marketing innovative and versatile laser-based medical systems and delivery devices. We provide solutions for multiple specialties, including ophthalmology, dermatology and otolaryngology. We maintain a deep commitment to the success of our customers, with comprehensive technical, clinical, and service support programs. IRIDEX is dedicated to a standard of excellence, offering superior technology for superior results. IRIDEX products are sold in the United States through a direct sales force and internationally through a combination of a direct sales force and a network of approximately 100 independent distributors into 107 countries. For further information, visit the Company's website at http://www.iridex.com.
SOURCE IRIDEX Corporation